{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:46:25Z","timestamp":1789055185790,"version":"build-2803163510"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The aim was to examine and summarize the most recent published literature in the last years stating the advances for treatment options and adjunctive therapies in patients hospitalized with severe community-acquired pneumonia (sCAP). Search was performed in PubMed, including observational studies, randomized controlled trials, systematic reviews and meta-analyses, and international guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Regardless of a large number of published CAP guidelines, most of their recommendations are based on low-level evidence.<\/jats:p>\n            <jats:p>Viruses have an increasing role as sCAP etiology with an impact on mortality. Accordingly, it is imperative to strengthen the demand for vaccines and newer antivirals. Considering an early monitoring of the immune response in patients with severe Influenza, may help to evaluate a personalized immunomodulatory strategy. Despite growing evidence, the use of corticosteroids as an adjunctive therapy in bacterial sCAP continues to be controversial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Mortality due to sCAP still remains undesirably high. This fact strengthens the need for more high-quality research to increase evidence. It also highlights the need for clinicians to be aware of the level of evidence of the stated recommendations, taking this into consideration before decision making.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000001083","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T03:18:44Z","timestamp":1693279124000},"page":"400-406","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Severe community-acquired pneumonia in the post COVID-19 era"],"prefix":"10.1097","volume":"29","author":[{"given":"Alfonsina","family":"Ruiz-Spinelli","sequence":"first","affiliation":[{"name":"Intensive Care Unit, Department of Critical Care, Hospital de Cl\u00ednicas, Facultad de Medicina, Universidad de la Rep\u00fablica, Montevideo, Uruguay"},{"name":"Department of Medicine, Universitat Internacional de Catalunya (UIC), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Waterer","sequence":"additional","affiliation":[{"name":"Respiratory Department, University of Western Australia, Royal Perth Hospital, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[{"name":"Global Health eCore, Vall d\u2019Hebron Institute of Research (VHIR), Barcelona"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain"},{"name":"Unit\u00e9 de Recherche FOVERA, R\u00e9animation Douleur Urgences, Centre Hospitalier Universitaire de N\u00eemes, N\u00eemes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10096-020-03870-3","article-title":"Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study","volume":"39","author":"Carugati","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of community-acquired pneumonia and unmet clinical needs","volume":"37","author":"Ferreira-Coimbra","year":"2020","journal-title":"Adv Ther"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"1701190","DOI":"10.1183\/13993003.01190-2017","article-title":"Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients","volume":"52","author":"Restrepo","year":"2018","journal-title":"Eur Respir J"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13613-018-0429-z","article-title":"Severe atypical pneumonia in critically ill patients: a retrospective multicenter study","volume":"8","author":"Valade","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12890-020-1115-0","article-title":"Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department","volume":"20","author":"Angrill","year":"2020","journal-title":"BMC Pulm Med"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1900057","DOI":"10.1183\/13993003.00057-2019","article-title":"Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study","volume":"54","author":"Webb","year":"2019","journal-title":"Eur Respir J"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2019.7495","article-title":"Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia","volume":"180","author":"Jones","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0040-1709992","article-title":"Staphylococcus aureus pneumonia in the community","volume":"41","author":"He","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/resp.13663","article-title":"Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia","volume":"25","author":"Villafuerte","year":"2020","journal-title":"Respirology"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20250729","first-page":"101253","article-title":"Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials","volume":"42","author":"Bouras","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R12-20250729","first-page":"101098","article-title":"Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: A systematic review","volume":"41","author":"Martinez-Reviejo","year":"2022","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13613-019-0559-y","article-title":"Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis","volume":"9","author":"Vidaur","year":"2019","journal-title":"Ann Intensive Care"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.chest.2021.12.670","article-title":"Characteristics and outcomes of patients in the ICU with respiratory syncytial virus compared with those with influenza infection: a multicenter matched cohort study","volume":"161","author":"Coussement","year":"2022","journal-title":"Chest"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.chest.2022.01.050","article-title":"Challenges in respiratory syncytial virus in adults with severe community-acquired pneumonia","volume":"161","author":"Rello","year":"2022","journal-title":"Chest"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1007\/s12325-022-02256-5","article-title":"Ribavirin for treatment of subjects with respiratory syncytial virus-related infection: a systematic review and meta-analysis","volume":"39","author":"Tejada","year":"2022","journal-title":"Adv Ther"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"574128","DOI":"10.3389\/fmed.2020.574128","article-title":"The clinical characteristics and outcomes of adult patients with pneumonia related to three paramyxoviruses","volume":"7","author":"Chen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1631\/jzus.B2000479","article-title":"Comparison of COVID-19 and influenza characteristics","volume":"22","author":"Bai","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(22)00383-X","article-title":"SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses","volume":"399","author":"Swets","year":"2022","journal-title":"Lancet"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1017\/ice.2021.96","article-title":"Bacterial coinfection in influenza pneumonia: rates, pathogens, and outcomes","volume":"43","author":"Bartley","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/path.2417","article-title":"Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients","volume":"216","author":"Deng","year":"2008","journal-title":"J Pathol"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2022.07.010","article-title":"Host response dysregulations amongst adults hospitalized by influenza A H1N1 virus pneumonia: a prospective multicenter cohort study","volume":"104","author":"Valenzuela-M\u00e9ndez","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/jpm12010084","article-title":"Plasma levels of mid-regional proadrenomedullin accurately identify H1N1pdm09 influenza virus patients with risk of intensive care admission and mortality in the emergency department","volume":"12","author":"Valenzuela-M\u00e9ndez","year":"2022","journal-title":"J Pers Med"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/14787210.2022.2040359","article-title":"Managing sepsis in the era of precision medicine: challenges and opportunities","volume":"20","author":"Watkins","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s12325-020-01347-5","article-title":"Alternative regimens of neuraminidase inhibitors for therapy of hospitalized adults with influenza: a systematic review of randomized controlled trials","volume":"37","author":"Tejada","year":"2020","journal-title":"Adv Ther"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejim.2020.12.010","article-title":"Neuraminidase inhibitors are effective and safe in reducing influenza complications: meta-analysis of randomized controlled trials","volume":"86","author":"Tejada","year":"2021","journal-title":"Eur J Intern Med"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/17512433.2021.1917378","article-title":"Neuraminidase inhibitors and single dose Baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomized controlled trials","volume":"14","author":"Tejada","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jpids\/piaa145","article-title":"Baloxavir treatment in adolescents with acute influenza: subgroup analysis from the CAPSTONE-1 trial","volume":"10","author":"Portsmouth","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with Baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(21)00469-2","article-title":"Combining Baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial","volume":"22","author":"Kumar","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jointm.2021.07.001","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA)","volume":"1","author":"Dimopoulos","year":"2021","journal-title":"J Intensive Med"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13054-021-03874-1","article-title":"Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study","volume":"26","author":"Rouz\u00e9","year":"2022","journal-title":"Crit Care"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2020.03.065","article-title":"Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis","volume":"81","author":"Bassetti","year":"2020","journal-title":"J Infect"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/cid\/ciy723","article-title":"Prevalence and etiology of community-acquired pneumonia in immunocompromised patients","volume":"68","author":"Di Pasquale","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-2600(18)30345-X","article-title":"Acute respiratory failure in immunocompromised adults","volume":"7","author":"Azoulay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1513\/AnnalsATS.202212-1019ST","article-title":"Immunocompromised host pneumonia: definitions and diagnostic criteria: an official American Thoracic Society Workshop Report","volume":"20","author":"Cheng","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia","volume":"48","author":"Meduri","year":"2022","journal-title":"Intensive Care Med"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","article-title":"Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis","volume":"47","author":"Chaudhuri","year":"2021","journal-title":"Intensive Care Med"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chest.2022.08.2229","article-title":"Effect of corticosteroids on mortality and clinical cure in community-acquired pneumonia: a systematic review, meta-analysis, and meta-regression of randomized control trials","volume":"163","author":"Saleem","year":"2023","journal-title":"Chest"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s10096-020-03833-8","article-title":"Levels of evidence supporting European and American community-acquired pneumonia guidelines","volume":"39","author":"Ferreira-Coimbra","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"e1611","DOI":"10.1093\/cid\/ciaa1452","article-title":"Clinical practice guidelines versus actual clinical practice: the pneumonia paradigm","volume":"73","author":"Rello","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:08:19Z","timestamp":1753819699000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000001083","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]}}}